BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Pharmacogenetics
,
Prozac
,
rs2300478
,
SNCA
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
thymic squamous cell carcinomas
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for thymic squamous cell carcinomas
Explore Curated Studies Results
Literature
Most Relevant Literature
Radical Removal of Low-Differentiation Thymic Squamous Cell Carcinoma: A Rare Clinical Case.
Robust and durable response to first-line treatment of pembrolizumab combined with chemotherapy in t…
Stage III-IV thymic squamous cell carcinoma in complete pathological remission achieved with thymic …
Durable efficacy of anlotinib in a patient with advanced thymic squamous cell carcinoma after multil…
Transformation from Small Cell to Squamous Cell Carcinoma in a Thymic Carcinoma Patient with a Durab…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
PT-112 in Subjects With Thymoma and Thymic Carcinoma
Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVEN…
Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
Feasibility Trial of Pembrolizumab in Unresectable Thymoma and Thymic Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ